Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid
NCT00174733
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
456
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Ciclesonide (XRP1526)
Sponsor
Sanofi